5 High Growth Stocks Insiders Are Buying

4. Neuronetics, Inc. (NASDAQ:STIM)

On July 6, 2026, Neuronetics, Inc. (NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled “Commercializing the Next Wave of Novel Neuropsychiatric Drugs” alongside Compass Pathways on Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day.

On June 2, Neuronetics announced its participation as a Silver Sponsor at the 2026 Clinical TMS Society Annual Meeting. The company said real-world data from its proprietary TrakStar database will be featured in an oral presentation and multiple scientific posters focused on transcranial magnetic stimulation for mental health conditions. Chief Technology Officer Cory Anderson said the expansion of real-world evidence is “critical” to advancing the understanding of TMS and its role in clinical practice.

Also on June 2, Neuronetics announced that Robert Greene was appointed Senior Vice President of Sales, effective June 1, 2026. Greene brings experience leading commercial strategy and sales organizations within healthcare and medical technology, including capital equipment and service.

Neuronetics, Inc. (NASDAQ:STIM) provides in-office treatments for patients with neurohealth disorders in the United States and internationally.

1281292 - 11759070 - 1